Marriott Stock Dips. Time to Buy?

Marriott shares slipped about 8% after management warned at a Barclays conference that fourth-quarter global RevPAR will likely print at the low end of guidance (1–2% growth) driven mainly by U.S. weakness—CFO Leeny Oberg said U.S. RevPAR fell ~20 basis points year‑over‑year in October and cited the government shutdown as a partial factor. The company still posted solid third‑quarter results (revenue $6.49 billion, +4% YoY; adjusted net income $674 million; adj. EPS $2.47, +9.2%), added ~17,900 net rooms in Q3 and has a record development pipeline of ~3,900 properties (≈596,000 rooms), enabling roughly $4 billion in planned shareholder returns. The takeaway for investors: near‑term U.S. demand softness could keep pressure on the stock, but durable cash generation, mid‑single‑digit room growth and luxury resilience support the case for a selective, size‑constrained buy while closely monitoring U.S. trends.

Analysis

Marriott shares declined roughly 8% over the past week after management warned at a Barclays conference that fourth-quarter global RevPAR will likely land at the low end of the 1%–2% guidance range, driven primarily by U.S. weakness; CFO Leeny Oberg noted U.S. RevPAR fell ~20 basis points year‑over‑year in October and cited a government shutdown as a partial contributor. The company reported Q3 revenue of $6.49 billion (up 4% YoY), adjusted net income of $674 million (from $638 million), and adjusted EPS of $2.47 (up 9.2%), while global RevPAR rose just 0.5% with U.S. & Canada down 0.4% and international up 2.6%.

Operationally, room growth remains the core growth driver: Marriott added ~17,900 net rooms in Q3 (net rooms +4.7% YoY), operates ~9,700 properties with ~1.75 million rooms, and has a record development pipeline of ~3,900 properties (~596,000 rooms) supporting management’s mid-single-digit room-growth target and enabling planned shareholder returns of ~ $4 billion this year. Luxury performance (global luxury RevPAR +4% in Q3), higher co-branded card fees and a fee-heavy model underpin robust cash generation, but the stock trades at a forward P/E of ~24, which the author characterizes as fair but not cheap.

Near-term risk centers on sustained U.S. demand softness concentrated in lower-priced chains; absent a U.S. recovery the stock could underperform despite secular positives from international and luxury segments. The situation warrants a selective, size-constrained entry for investors who accept cyclical downside and will actively monitor U.S. RevPAR and Q4 prints as the primary catalysts that could materially change the outlook.

Key Decisions for Investors

• Consider initiating a small, size‑constrained long position to participate in Marriott’s durable cash generation and mid‑single‑digit room growth, given Q3 revenue of $6.49B, adj. EPS of $2.47, and $4B in planned shareholder returns
• Monitor U.S. RevPAR trends and government travel flows closely—if U.S. RevPAR continues to decline past October’s ~20 bps drop or Q4 misses guidance, reduce exposure or hedge because U.S. weakness drives the company’s near‑term downside
• Prefer exposure to Marriott’s luxury and international recovery narratives (luxury RevPAR +4% in Q3, international RevPAR +2.6%) and avoid increasing position size until valuation compresses below the current forward P/E of ~24 or confidence in a sustained U.S. demand rebound increases